fda approved glp-1 receptor agonists list Advancements in approvals for pediatric obesity treatment How Employers Can Optimize Benefits
Description
2025;30(4) doi: 10.1016/J.DRUDIS.2025.104333
39 Obstructive sleep apnea Obstructive sleep apnea is another obesity-associated condition in which GLP-1 RAs may offer therapeutic benefit
Graphical Abstract Keywords Metabolic dysfunction-associated steatotic liver disease, Glucagon-like peptide-1 receptor agonist, Clinical trial, Treatment, Metabolic dysfunction-associated steatohepatitis, Fibrosis Introduction Nonalcoholic fatty liver disease has been used to describe hepatic steatosis without significant alcohol intake
Remodeling the gut microbiome is metabolically demanding
61 In clinical trials of liraglutide for MASLD, the dose setting is still mainly based on the diabetes condition
